Abstract
Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) is a mitochondrial inner membrane protein and plays an important role in mitochondrial ATP production and biogenesis. High expression levels of LETM1 have been correlated with numerous human malignancies. This study explored the clinicopathological significance of LETM1 expression as a prognostic determinant in head and neck squamous cell carcinoma (HNSCC). HNSCC samples from 176 patients were selected for immunohistochemical staining of LETM1 protein. Correlations between LETM1 overexpression and clinicopathological features of HNSCC were evaluated by Chi-squared tests and Fisher's exact tests, and relationships between prognostic factors and patient survival were analyzed using Cox proportional hazards models. Our results demonstrated that the strongly positive rate of LETM1 protein was 65.3% in HNSCC, which was significantly higher than in either adjacent nontumor tissue (25.0%) or normal squamous epithelia (6.7%). LETM1 overexpression correlated with poor differentiation, presence of lymph node metastasis, advanced stage, absence of chemoradiotherapy, and 5-year disease-free survival and overall survival rates in HNSCC. Further analysis showed that high LETM1 expression, advanced stage, and nonchemoradiotherapy were significant independent risk factors for mortality in HNSCC. In conclusion, LETM1 plays an important role in the progression of HNSCC and is an independent poor prognostic factor for HNSCC.
Highlights
Head and neck squamous cell carcinoma (HNSCC) is one of the leading malignancies worldwide [1]
We found that the strongly positive rate of Leucine zipper-EF-hand containing transmembrane protein 1 (LETM1) protein was significantly higher in poorly differentiated HNSCC (80.6%, 29/36) than in well (55.9%, 33/59) and moderately (65.4%, 53/81) differentiated cases (P = 0.016)
We have demonstrated that LETM1 expression may be one of the independent prognostic factors, along with tumor stage and chemoradiotherapy
Summary
Head and neck squamous cell carcinoma (HNSCC) is one of the leading malignancies worldwide [1]. It is recognized that most cancer cells predominantly produce energy by glycolysis in the BioMed Research International cytoplasm, rather than by oxidative phosphorylation in mitochondria like most normal cells. The importance of this Warburg effect is further underlined by recent studies that report that impaired mitochondrial function renders cancer cells resistant to apoptosis and chemotherapy [12,13,14]. Recent studies report that LETM1 may function in mitochondrial biogenesis, which is an important feature of human cancer. Piao et al reported that LETM1 induced necrotic cell death in HeLa cervical cancer cells by inhibiting mitochondrial biogenesis and mitochondrial ATP production [15]. The role of LETM1 protein in prognostic evaluation and its relationship with survival in HNSCC remain unknown
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.